Your browser doesn't support javascript.
loading
New insights into the type A glycan modification of Clostridioides difficile flagellar protein flagellin C by phosphoproteomics analysis.
Hensbergen, Paul J; de Ru, Arnoud H; Friggen, Annemieke H; Corver, Jeroen; Smits, Wiep Klaas; van Veelen, Peter A.
Affiliation
  • Hensbergen PJ; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: P.J.Hensbergen@lumc.nl.
  • de Ru AH; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
  • Friggen AH; Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Corver J; Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Smits WK; Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
  • van Veelen PA; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
J Biol Chem ; 298(3): 101622, 2022 03.
Article in En | MEDLINE | ID: mdl-35065968
ABSTRACT
The type A glycan modification found in human pathogen Clostridioides difficile consists of a monosaccharide (GlcNAc) that is linked to an N-methylated threonine through a phosphodiester bond. This structure has previously been described on the flagellar protein flagellin C of several C. difficile strains and is important for bacterial motility. The study of post-translational modifications often relies on some type of enrichment strategy; however, a procedure for enrichment of this modification has not yet been demonstrated. In this study, we show that an approach that is commonly used in phosphoproteomics, Fe3+-immobilized metal affinity chromatography, also enriches for peptides with this unique post-translational modification. Using LC-MS/MS analyses of immobilized metal affinity chromatography-captured tryptic peptides, we observed not only type A-modified C. difficile flagellin peptides but also a variety of truncated/modified type A structures on these peptides. Using an elaborate set of mass spectrometry analyses, we demonstrate that one of these modifications consists of a type A structure containing a phosphonate (2-aminoethylphosphonate), a modification that is rarely observed and has hitherto not been described in C. difficile. In conclusion, we show that a common enrichment strategy results in reliable identification of peptides carrying a type A glycan modification, and that the results obtained can be used to advance models about its biosynthesis.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clostridioides difficile / Flagellin Language: En Journal: J Biol Chem Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clostridioides difficile / Flagellin Language: En Journal: J Biol Chem Year: 2022 Type: Article